首页 › 基金 › CIBRA Capital Ltd › TERN
CIBRA Capital Ltd 对 TERN 的持仓历史
TERNS PHARMACEUTICALS INC
CIBRA Capital Ltd 在 Q1 2026 的 13F 申报中披露持有 TERN(TERNS PHARMACEUTICALS INC)151,440 股,市值约 US$8.0M,约占其申报组合的 3.85%,在其申报持仓中市值排名第 12 位。 CIBRA Capital Ltd 于 Q1 2026 首次申报该持仓。
最后更新: 2026-10-18 · 来源: SEC EDGAR Form 13F-HR
CIBRA Capital Ltd 对 TERN 的持仓演变
CIBRA Capital Ltd 于 Q1 2026 首次披露 TERN 持仓:151,440 股(约 US$8.0M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2026 | 151.44K | $7.98M | 新进 |
关于 TERN 与 13F 数据
TERN(TERNS PHARMACEUTICALS INC)的行业分类暂缺。我们追踪的基金中还有 3 只申报持有 TERN。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
更多关于 CIBRA Capital Ltd
常见问题
How long has CIBRA Capital Ltd held TERN?
CIBRA Capital Ltd has disclosed TERN holdings in 1 of the last 1 reported quarters, going back to Q1 2026.
What is CIBRA Capital Ltd's current position in TERN?
As of Q1 2026, CIBRA Capital Ltd holds 151.44K shares of TERN (TERNS PHARMACEUTICALS INC), valued at $7.98M, representing 3.85% of its reported portfolio and ranking #12.
Has CIBRA Capital Ltd been buying or selling TERN?
In the latest 13F filing (Q1 2026), CIBRA Capital Ltd newly opened its position in TERN.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.